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ABSTRACT
Objectives: Locally led health research in low and
middle income countries (LMICs) is critical for
overcoming global health challenges. Yet, despite over
25 years of international efforts, health research
capacity in LMICs remains insufficient and
development attempts continue to be fragmented. The
aim of this systematic review is to identify and critically
examine the main approaches and trends in health
research capacity development and consolidate key
thinking to identify a more coherent approach.
Methods: This review includes academic and grey
literature published between January 2000 and July
2013. Using a predetermined search strategy, we
systematically searched PubMed, hand-searched
Google Scholar and checked reference lists. This
process yielded 1668 papers. 240 papers were selected
based on a priori criteria. A modified version of
meta-narrative synthesis was used to analyse the
papers.
Results: 3 key narratives were identified: the effect of
power relations on capacity development; demand for
stronger links between research, policy and practice
and the importance of a systems approach. Capacity
development was delivered through 4 main modalities:
vertical research projects, centres of excellence,
North–South partnerships and networks; all were
controversial, and each had their strengths and
weaknesses. A plurality of development strategies was
employed to address specific barriers to health
research. However, lack of empirical research and
monitoring and evaluation meant that their
effectiveness was unclear and learning was weak.
Conclusions: There has been steady progress in LMIC
health research capacity, but major barriers to research
persist and more empirical evidence on development
strategies is required. Despite an evolution in
development thinking, international actors continue to
use outdated development models that are recognised
as ineffective. To realise newer development thinking,
research capacity outcomes need to be equally valued
as research outputs. While some development actors
are now adopting this dedicated capacity development
approach, they are in the minority.
INTRODUCTION
Locally led health research is critical for over-
coming global health challenges in low and
middle income countries (LMICs).1 This
research is needed to “propose culturally apt
and cost-effective individual and collective
interventions, to investigate their implemen-
tation, and to explore the obstacles that
prevent recommended strategies from being
implemented”.2 Such research is now the
focus of key capacity development efforts,
such as the regional educational centres sup-
ported by the Special Programme for
Research and Training in Tropical Diseases
(TDR).3
However, these arguments are not new; the
importance of LMIC research capacity has
been recognised for well over two decades.
The 1990 Commission on Health Research
Strengths and limitations of this study
▪ This systematic review goes beyond previous
attempts that lacked reflexivity, to provide a
nuanced, in-depth and enquiring critique of health
research capacity development approaches.
▪ This review integrates diverse qualitative litera-
ture that largely lacked formal reporting proce-
dures or empirical base, allowing the inclusion
of voices that are traditionally excluded in other
styles of systematic analyses.
▪ Some academic articles may have been missed
because PubMed was the only formal database
used, and there was limited inclusion of evalu-
ation and programme-level data due to poor grey
literature indexing in Google and Google Scholar.
▪ However, the meta-narrative method aims to
develop overarching narratives through saturation
of themes, rather than include every eligible
article, so inclusion of additional papers would
be unlikely to change the findings of the study.
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for Development stated that strengthening research cap-
acity in LMICs is “one of the most powerful, cost-
effective, and sustainable means of advancing health
and development”.4 This marked the beginning of a
‘revolution’ in health research5 where there was a surge
of investment and concerted effort to conduct health
research aimed at solving health problems in LMICs.6
Nevertheless, at the turn of the millennium LMICs
accounted for 85% of the world’s population, 92% of
the global disease burden, but only 10% of global
funding for health research was devoted to addressing
these persistent health challenges.6 Recognition of this
‘10/90’ gap led to renewed calls for health research cap-
acity development (HRCD) in LMICs and further
investment.5
Yet nearly 15 years later, many LMICs still lack sufﬁ-
cient health research capacity to build a local evidence-
base with which to inform policy and improve population
health. This was recently and profoundly described in
The 2013 World Health Report which argued that ‘all
nations should be producers and users of research as
well as consumers’, noting that this was not yet the case.1
Therefore, despite years of international collabora-
tions and investment, development of LMIC nation’s
capacity to address their own health problems appears
enduringly problematic. Where there has been progress,
such gains often do not appear sustainable without con-
tinued strong foreign support,7 8 which is itself question-
able in light of recent austerity and bilateral aid agency
restructuring.1 9 10
Although there is a large and diverse body of literature
on HRCD, it remains confusing, controversial and poorly
deﬁned, with various contradictory understandings11
and conceptualisations.1 Because capacity development
is now something that most research actors are expected
to participate in, or at least be knowledgeable on,5 12 this
is problematic. To increase the likelihood of future cap-
acity development efforts being effective, there is a need
to take stock of past experiences and learn from suc-
cesses and failures. Such an exercise would not only
provide a unifying picture to appraise previous capacity
development efforts, but also encourage discussion and
reﬂection that could lead to fresh thinking.
The aim of this systematic review is to identify and crit-
ically examine the main approaches, strategies and
trends in HRCD and consolidate key thinking in order
to identify a more coherent approach. This review
should prove useful to all stakeholders interested in
learning how to undertake the complex business of cap-
acity development and will be of particular interest to
actors working to make locally led and sustainable
health research capacity in LMICs a reality.
METHODS
Our systematic review followed the six stages of the meta-
narrative methodology developed by Greenhalgh et al.13
The meta-narrative method is a “systematic, theory-
driven interpretative technique, which [was] developed
to help make sense of heterogeneous evidence about
complex interventions applied in diverse contexts in a
way that informs policy”.14 Since the HRCD literature
shares these characteristics, the meta-narrative method
was highly suited to the purposes of this study.
Inclusion criteria
This review considers the perspectives of all actors
involved in HRCD that have published within academic
and grey literature from the year 2000 onwards. We
included any papers that broadly discussed HRCD or its
more speciﬁc components. Papers that mentioned
HRCD but did not discuss the issue further were not
included. Non-English language publications were
excluded due to lack of resources for translation. Papers
published before the year 2000 were initially included,
but after screening it became clear that paradigm shifts
in global health at the turn of the millennium5 6 meant
that much of their content was not relevant to current
day. Furthermore, many papers published post-2000
effectively summarised historically important issues.
Therefore, all papers published pre-2000 were excluded.
Search strategy and study selection
The search and study selection process is presented in
ﬁgure 1. We searched PubMed using the search terms
presented in box 1 for all papers published up to 20
June 2013. This search yielded 1668 potentially relevant
papers. The titles and abstracts of these papers were
then screened for eligibility, resulting in 1376 papers
being excluded based on prescreening, with an add-
itional 75 papers excluded after it was decided that
papers published before 1 January 2000 should not be
included.
The PubMed search was complemented by a search of
Google and Google Scholar using the terms ‘Health
AND research AND capacity AND strengthening OR
Building OR Development’. All literature added from
Google were found in the ﬁrst 10 pages (n=30). After
the ﬁrst 10 pages, no search results were relevant to the
study. Literature collections of the authors and other
experts were also hand searched and references snow-
balled (n=45). A total of 292 papers were read in full
and considered for eligibility. On the basis of this screen-
ing, the ﬁnal synthesis involved 240 papers. The full list
of papers included in this review can be found in online
supplementary ﬁle S1.
Relevant papers published between 20 June 2013 and
14 December 2014 were scanned and read to determine
if the synthesis ﬁndings were still valid postsearch.
Although there were some pertinent new articles, their
content would not have changed the ﬁndings of this
synthesis.
Quality assessment
No papers were excluded based on assessment of quality
because the majority of papers lacked an empirical or
2 Franzen SRP, et al. BMJ Open 2017;7:e012332. doi:10.1136/bmjopen-2016-012332
Open Access
explicit study design, and all stakeholders’ views regard-
less of their perceived validity were considered import-
ant. Furthermore, capacity development discussion is
inherently political and most contributions are based on
personal opinion informed by theoretical, ethical or
experiential standpoint. Accordingly, much of it is
biased. Rather than attempt to remove the bias, assump-
tions and motivations were explicitly studied to under-
cover authors’ implicit logic, so that readers can make
their own informed opinion.
Instead of using quality criteria, similarity of argu-
ments within the literature was used as an indicator of
current agreement on a topic or popularity of an idea.
This allowed a comprehensive analysis of all the HRCD
narratives, while still highlighting and giving emphasis to
the most widely accepted opinions.
Data extraction and synthesis
To synthesise the literature, papers need to be framed
within a ‘storyline’ that recognises where the contribu-
tion came from.13 Greenhalgh et al’s13 method explicitly
catalogues these storylines as ‘meta-narratives’.
Developing meta-narratives provides context to contribu-
tions whose underlying assumptions and interests would
Figure 1 Search and study
selection process.
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otherwise be opaque. Although less prescribed than a
quantitative systematic review, this approach pragmatic-
ally allows a plurality of ideas, recognising that there may
be no single correct answer.
To ensure that source content was interpreted along-
side its context, even when broken into themes and nar-
ratives, a tagging system was used instead of a traditional
extraction form. All sources were organised in EndNote
X7 (Thomson Reuters), and associated citations, meta-
data and PDF copies of the documents were attached.
These data were then imported into Nvivo V.9 qualitative
analysis software (QSR International) where the sources
were given tags using deductive codes for key
characteristics.
Meta-narratives were then identiﬁed inductively by
reading each paper and coding for meta-narratives
where several authors in the literature discussed and pre-
sented topics similarly. This is an interpretive approach
similar to that used in thematic coding analysis, where
reoccurring themes that are conceptually related are
grouped into concepts. Once the meta-narratives had
been ﬁnalised, they were systematically applied to all
relevant papers. No prior theory beyond the guidance
presented by Greenhalgh et al13 was explicitly used to
help identify and categorise the meta-narratives. Instead,
iterative rounds of open data-driven inductive coding
were used.
Role and position of the authors
This systematic review was undertaken, in part, to inform
the design of a larger body of empirical research on
HRCD in LMICs. All authors have backgrounds in social
science and global health. Initial coding was conducted
by Samuel Franzen and then reﬁned based on
face-to-face discussions with other authors around the
coding framework and preliminary ﬁndings. The
authors of this paper do not include individuals from
LMICs, but this paper was reviewed and commented on
by individuals from LMICs who collaborated on and par-
ticipated in the parallel empirical research, and dis-
cussed with other relevant experts at meetings and
conferences. These team processes represent a deviation
from the meta-narrative method presented by
Greenhalgh et al,13 because the authors did not consti-
tute a multidisciplinary team and input from external
peers was largely ad hoc, rather than through regular
planned inputs. These methodological deviations were
required to enable the systematic review to feed into the
evolving parallel empirical research.
RESULTS
Definitions and actors
The concept of capacity development can be confusing
because there are multiple and conﬂicting terminologies
for development activities and actors. To assist the
reader, typologies of key deﬁnitions and development
actors were produced. Online supplementary ﬁle S2 pre-
sents these deﬁnitions alongside reasons for adopting
them, and online supplementary ﬁle S3 categorises and
provides background to development actors’ activities.
Characteristics of included papers
Table 1 summarises the main characteristics of the
papers included in the review. On the basis of ﬁrst
author characteristics, the greatest number of articles
came from LMIC academic and healthcare institutions
(31.3%), closely followed by high income countries’
(HIC) academic and healthcare institutions (29.6%).
Contributions from funders were very low (0.8%), and
industry and civil society were absent, potentially reﬂect-
ing the sampling from academic databases. Europe was
the greatest contributing region (32.9%) followed by
sub-Saharan Africa at 23.8% and North America at
13.8%. Contributions from Latin America (2.5%),
Middle East (1.7%) and North Africa (0.8%) were low.
Although most articles were concerned with capacity
development across all LMICs (42.1%), sub-Saharan
Africa dominated the regional speciﬁc discussions
(34.6%). The main basis for viewpoints were opinion,
debate or personal perspectives (34.2%); sharing experi-
ences represented 21.7%, and empirical work 20.8%.
Meta-narratives in HRCD
Three key narratives ran though the literature: the effect
of power relations on capacity development; demand for
stronger links between research, policy and practice and
the importance of a systems approach to HRCD. Each
narrative is described below with reference to the key
papers that discussed these narratives in detail.
Effect of power relations on capacity development
The effect of power relations on capacity development
was the most common narrative running through the lit-
erature (present in 29% of papers). The main concerns
of this topic are that research agendas in LMICs are set
more by international funders than by LMIC institutions,
and research conducted in LMICs is predominantly led
by HIC researchers with little involvement of LMIC indi-
viduals or institutions. This is argued to erode national
sovereignty,15 prevent capacity development16 17 and
Box 1 Search terms used in PubMed search
(((((((((((((((((capacity building[MeSH Terms]) OR (((“developing”
[Title/Abstract]) OR “develop”[Title/Abstract]) OR “capacity”[Title/
Abstract])))) OR “strengthen”[Title/Abstract]) OR “strengthening”
[Title/Abstract])) AND ((((developing country[MeSH Terms]) OR
Africa) OR Asia) OR Latin America))) AND (((“trial”[Title]) OR
“trials”[Title]) OR “research”[Title])))) NOT clinical trial[Publication
Type]) NOT informed consent[MeSH Terms]) NOT waste manage-
ment[MeSH Terms]) NOT air pollution[MeSH Terms]) NOT
agriculture[MeSH Terms]) NOT (“Na6(H2O)8(ZnAsO4)6”
[Supplementary Concept] OR “K3Zn4O(AsO4)3” [Supplementary
Concept]).
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Table 1 Characteristics of papers included in this review
Category* of
development actor
(for first author)
Per
cent
Location of
first author’s
institution
Per
cent
Region of
interest
Per
cent
Main topic of
development
interest
Per
cent
Main disease of
interest
Per
cent
Basis for
viewpoint
Per
cent
LMIC academic and
healthcare institutions
31.3 Europe 32.9 All LMIC
countries
42.1 Multiple broad
issues discussed
24.6 Not disease specific or
address multiple
72.5 Opinion, debate,
perspective
34.2
HIC academic and
healthcare institutions
29.6 Sub Saharan
Africa
23.8 Sub
Saharan
Africa
34.6 Individual level
development
15.8 HIV 6.3 Experience report 21.7
Multilaterals 10.4 North America 13.8 South Asia 10 Partnerships
networking,
consortia
15.8 Malaria 5.8 Empirical
research
20.8
Consortia and
networks, NGOs and
public–private
partnerships
8.8 South Asia 10 East Asia 6.7 Operational
challenges and
opportunities
11.3 Other 4.6 Literature review,
summary or
synthesis
7.9
Academic journals 5.4 East Asia 9.2 All Asia 2.9 System approaches
and macrolevel
development
9.2 Mental health and
addiction
2.5 Proceedings or
conference report
7.5
LMIC governmental 4.6 Australia 2.9 Latin
America
1.7 Agenda and priority
setting
6.3 Maternal child health
and paediatrics
2.5 Organisation
document
4.6
LMIC funders, research
councils and institutes
of health
4.6 Latin America 2.5 Pacific 0.8 Institution level
development
5.4 Tuberculosis 2.1 News report 3.3
Bi-lateral aid agencies 2.1 Not specific 2.1 Middle
East
0.8 Monitoring and
evaluation
2.9 Non-communicable
diseases
2.1
HIC research councils
and institutes of health
2.1 Middle East 1.7 Central
Asia
0.4 Research and
development
2.1 Dental or oral health 1.7
Private foundations or
charity funders
0.8 North Africa 0.8 Ethics and
regulations
1.7
Industry 0 Pacific 0.4 Knowledge cycle 0.8
Civil society and media 0
*Some categories have been merged because they could not be separated.
HIC, high income countries; LMIC, low and middle income countries; NGOs, non-governmental organisations.
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create research priorities that more closely match funder
agendas than countries’ needs18–20 leading to a situation
of ‘he who pays the piper calls the tune’.20 21 Examples
include ‘spotlight issues’, which receive funding regard-
less of relative need,22 and ‘parachute’ research where
data are collected in LMICs but all other work is con-
ducted in HIC institutions.
‘North–South’ collaborations between HIC and LMIC
research institutions are considered to be better
mechanisms for developing research capacity,8 but many
authors still thought that they comparatively disadvan-
tage the LMIC partner.9 12 15 The perceived situation of
‘treating Africa as a repository of raw materials for
expatriate-driven research’9 led to the development of
guidelines for research collaboration. To reﬂect the
change in approach, there was a rhetorical shift to using
the term ‘partnership’ to describe collaborations that
were equitable.17 These partnerships should be built on
mutual trust and shared decision-making, national own-
ership, early planning for translation of research ﬁnd-
ings and development of national research capacity.17
Importantly, it is now expected that all partnerships
should have capacity development at their forefront.12
However, despite discussion for well over a decade, a
good proportion of the international community still
feels that partnerships are not yet equal,12 23 24 and they
cannot be until the power divide is addressed15 because
LMICs are unable to negotiate for a fairer deal.15 25 26
In an effort to adjust the power balance, there have
been conscious efforts towards recognising local
research capacity in LMICs.12 20 This change is again
reﬂected in rhetoric through the evolution of the term
‘capacity development’ which gradually places stronger
emphasis on extant capacity; changing from ‘capacity
building’ to ‘capacity strengthening’20 to ‘capacity utilisa-
tion’,27 ‘unleashing’ and ‘releasing’.20 Many authors now
propose that research and capacity development in
LMICs should be locally owned and led.17 20 28 29 This is
because LMIC researchers have the best understanding
of evidence gaps17 and can present research to policy-
makers with an understanding of the political and cul-
tural context which increases the chance of evidence
uptake.30 31 Locally led studies are also thought to be
better aligned with national agendas32 and address more
applied implementation topics than foreign-led
research.17
Most stakeholders now agree that research and cap-
acity development should, at a minimum, include the
local research community in the design and conduct of
research studies.33 Development actors are also advised
to be more sensitive to the power dynamics they create
and ensure they strengthen, not weaken, the role of
national governments by responding speciﬁcally to their
priorities20 29 34 and including the ‘recipients’ in any
agenda setting.35 However, others argue that this situ-
ation will inevitably continue so long as foreign coun-
tries are the majority ﬁnanciers of research in LMICs;36
only through greater national investment and
commitment will LMICs have a stronger voice to make
relations more equitable.7 9 37 Nevertheless, the vast
majority of development efforts reportedly still focus on
international collaborative research meaning local
investigator-led studies are largely ignored.38 This is evi-
denced by only three papers in this review being
focused on supporting locally led clinical trials, com-
pared to 33 papers aimed at developing international
clinical trials.
Demand for stronger links between research, policy and
practice
Arguments for stronger links between research, policy
and practice were present in 16% of sources. These
emerged due to concerns that much research was failing
to be translated into policy25 39 and was too narrowly
conceived and disease-speciﬁc to have impact.40
Accordingly, applied ﬁelds now deemed to be highly
relevant to decision makers and those that promote sus-
tainable adoption and implementation of evidence-
based medicine have been called for.30 41 42 These
include health policy and systems research,43 health ser-
vices research,44 implementation research and opera-
tions research.45–47 These arguments formed the
backbone of the WHO strategy on ‘research for health’
which “gives priority to research and innovation that has
the greatest potential to improve global health security,
accelerate health-related development, redress health
inequities and help to attain the Millennium
Development Goals”.48
Despite these discussions, much research is still
regarded as uncoordinated and concentrating on a few
high proﬁle diseases49 such as the ‘big 3’: HIV/AIDS,
malaria and tuberculosis. Furthermore, the majority of
research is critiqued as largely technology development
focused, even though many argue that the impact of this
research is low44 and more lives could be saved by improv-
ing service delivery of existing interventions.25 43 50
The importance of a systems approach to capacity
development
The importance of taking a systems approach to HRCD
was discussed in 24% of sources. Conceived in the 1990s
and popularised after the Ministerial Summit on Health
Research in Mexico in 2004,25 systems approaches to
HRCD emerged in response to perceived failings of cap-
acity development targeted at only one level. Particular
weaknesses cited included: lack of provision for trained
individuals to use their skills6 leading to ‘brain drain’ of
LMIC researchers to HICs;51 52 exclusively focusing on
high performing individuals53 rather than strengthening
local institutions to develop researchers;54 absence of
national bodies to coordinate priorities, develop policy
and translate evidence into action55 and the fragmenta-
tion of capacity development activities.56 57
Proponents of systems approaches argue that for cap-
acity development to be effective and sustainable,8 58 new
approaches to addressing all three levels of the national
6 Franzen SRP, et al. BMJ Open 2017;7:e012332. doi:10.1136/bmjopen-2016-012332
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research system are needed; macro, institutional and
individual58 (for deﬁnitions of these levels, see online
supplementary ﬁle s2). Macrolevel capacity development
should include: priority setting, planning and coordinat-
ing research, governance and regulation and knowledge
translation and dissemination.48 57 59 Individual develop-
ment should include a broader range of stakeholders
than just research producers (eg, policymakers, adminis-
trators, medical personnel and ethics board members)
and teach a wider variety of skills and disciplines, particu-
larly ‘soft skills’ such as organisation, management and
leadership.55 Institutional development should focus on
the ability to generate, retain and use individual capacity
through improving curricula, training support, mentor-
ship and research resources.60–62
Although presented as a complex task with long time
frames,63 taking a systems approach is said to result in
more dynamic capacity development that produces
endogenous change, greater local ownership and
removal of perennial system barriers20 which helps coun-
tries to effectively target their own health needs.19 This
is in stark contrast to previous approaches that estab-
lished parallel structures to deliberately bypass local
systems because they were deemed to be chronically
ineffective.24 However, despite the accepted importance
of research systems development, little is known about
how health research systems can be formed,19 there are
few successful examples of research system strengthening
and little guidance is available.64
A summary of modern HRCD modalities
After attempts at aligning human, material and technical
capacities failed in the 1980s, research models that direc-
ted funds and technology through HIC institutions
became the preferred HRCD mechanism.5 These
mechanisms are now the most common approach to
HRCD. The justiﬁcation for requiring LMICs to collab-
orate with HICs is that knowledge transfer and HIC
expertise are required to achieve capacity develop-
ment.65 66 However, others argue that such development
models propagate inequities in research and develop-
ment.17 36 Discussions on development modalities are
therefore contentious. The following sections summarise
the justiﬁcations, beneﬁts, drawbacks and controversies
of the main development modalities.
Vertical research projects
One of the earliest and most persistent research models
arising from the HIC fund channelling mechanism was
vertical research projects.5 This involves a HIC research
collaborator working in a LMIC to conduct applied, nor-
mally short-term research projects with narrow objec-
tives.54 The theoretical advantage of a vertical strategy is
that it maintains focus on a speciﬁc scientiﬁc mission.67
This allows the necessary capacity to be developed more
rapidly and can quickly produce research outputs5 even
where major expansion of R&D is required.35 These
approaches now account for the biggest share of health
research funding.58 Examples include product develop-
ment partnerships such as The Global Alliance for TB
Drug Development, and many commercial or non-
commercial clinical trials.68
HRCD is often included in these programmes, but
development of capacity is usually not the primary
objective.59 Rather it is designed to develop capacities
that will beneﬁt the successful completion of the
project60 and result in high-quality research outputs.54
Vertical projects often have strong expatriate leadership
and are frequently managed by external institutions,54
which is argued to result in parallel structures that
bypass local research institutions.69 Where individual-
level development is provided, it is typically short term
and project speciﬁc.70
Critics of vertical projects argue that local researchers
often only have support roles,16 samples may be shipped
abroad for analysis23 and there can be little investment
in local institutions because they are bypassed.15 69
Therefore when these short-term projects ﬁnish,
research sites and individuals are rarely left with the
skills or resources to run their own studies.41 68 Another
criticism is that vertical approaches force the research
community to work separately on overlapping issues71
leading to fragmentation of national research systems.55
Proponents of vertical interventions are however
mindful that there is a trade-off between the speed and
quality of research, and capacity development.72 They
argue that in the case of health emergencies, investment
should be made in excellent research, not excellent cap-
acity development.
Centres of excellence
A common modality for developing long-term capacity
to conduct advanced research in LMICs is ‘centres of
excellence’. These have taken various forms, but the
approach generally concentrates investment within a few
institutions that show potential to excel and become
high-quality self-sustaining sites. These models are
reportedly useful because they increase the likelihood of
high-quality research and renewed investment in an
otherwise challenging environment.52 55 73
Early forms of this concept were criticised as being
‘annexed’ research sites, effectively led and managed by
expatriate staff.74 Others argue that they create parallel
research structures outside of the national system that
further depletes the local resource pool by diverting
investment and human resources towards these better
funded sites.17 24 44 More recent forms of ‘centres of
excellence’, such as those championed by the European
and Developing Countries Clinical Trials Partnership,
strive for greater Southern leadership and better integra-
tion with local research systems.75
North–South partnership
Another common development model is North–South
partnerships. They are distinct forms of collaboration
between HIC and LMIC researchers because unlike
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‘centres of excellence’, they are usually project speciﬁc
rather than institution building, and they put more
emphasis on sustainable research, shared leadership and
mutual beneﬁt than vertical research projects. However,
depending on the nature of the partnership, these
demarcations can become blurred.
Since the millennium, North–South partnerships and
have been heavily promoted by organisations such as
The Global Forum for Health Research6 and The
European and Developing Countries Clinical Trial
Partnership (EDCTP).75 Such partnerships are said to
be responsible for increasing resource ﬂows to LMICs31
and have been advocated for: increasing scientiﬁc prod-
uctivity,76 training of graduates, staff exchange and
knowledge sharing, exposure to cutting edge technol-
ogy,52 strengthening local education programmes and
moderate levels of institutional strengthening.6 77 78 This
is argued to result in more sustainable development,54
greater cost-efﬁciency and a broader research scope
than exclusively expatriate-led or locally led research
could achieve alone.17 20
Despite their popularity, a greater proportion of the
literature is dedicated to discussing problems with
North–South partnerships than their beneﬁts. Many
authors still feel that despite much guidance for enter-
ing into partnerships,12 17 53 79 80 too few beneﬁts are
accrued by the Southern partner9 12 23 24 81 because
they are forced to collaborate with HIC institutions to
meet funding requirements.82 Accordingly, LMIC part-
ners are reported to sometimes receive little ﬁnancial
beneﬁt, go unrecognised in publications and release
intellectual property rights.9 12 Proposed amendments
to this model have involved adapting partnerships to be
driven by LMIC demand,60 led by the Southern
partner20 or supporting more South–South
partnerships.28 83
Networks and consortia
Networks and consortia development models emerged
in the mid-1990s. By the mid-2000s, they were used to
tackle whole programmes of research60 and are now very
popular with funders.60 Actors adopting network models
are highly diverse and can sometimes be hard to separ-
ate from partnership models or vertical programmes.
However, they all involve linking multiple research
departments, groups or institutions.
Networks are considered advantageous because they
encourage less-hierarchical leadership and competitive
and individualistic attitudes. They are therefore report-
edly useful for working cooperatively on shared pro-
blems at regional or global levels.84 85 Because networks
facilitate information exchange and pooling of resources
to achieve a critical mass,86 they are seen as particularly
important where groups may be isolated87 or when one
group alone would have insufﬁcient capacity to address
an issue.88 Networks are also thought to: help focus on
common research priorities;60 89 increase knowledge
exchange and speed diffusion of innovations57 64 and
help forge long-term relationships5 87 and sustainabil-
ity.37 86 90 91 However, some authors point out that most
networks focus on highly thematic research projects60
and only develop capacity of individual research groups,
not research systems.87
Specific development strategies
The reviewed literature contained a multitude of devel-
opment strategies targeted at all levels of the health
research system; macro, institutional and individual.
These are presented in table 2 and grouped according
to the barrier that they address. The research barrier
groupings were identiﬁed by the authors through the-
matic coding of the literature content. The popularity of
the development strategies are indicated as a percentage
of the reviewed sources that proposed them as a solution
to a health research barrier.
Reported success and effectiveness of development
efforts
Broadly, authors consider capacity to conduct health
research in Africa to have increased considerably since
the millennium12 with potential to leverage further
gains from current efforts.59 This is best exempliﬁed by
increases in the number of clinical trials conducted in
LMICs103 123 with reports of enhanced trial capacity,68
particularly laboratories124 and quality standards,38 115 125
and greater LMIC inclusion.105 126 Such institutional
strengthening is also thought to have helped reduce
brain drain in speciﬁc cases.107 Although some countries
still lag behind in regulatory and ethical review capacity,
several publications indicate that LMICs have made
good progress.89 127
The increase in research capacity is thought to have
been driven by recognition of the importance of health
research over the last 20 years,5 a revised strategic
focus30 and the expansion of networks and partnerships
for addressing research needs.60 67 91 However, it is not
possible to attribute success to these development
approaches due to lack of monitoring and evaluation
data; in Africa, positive outcomes in the quality and
quantity of published research have been
recorded,60 107 128 but their connection to development
inputs and outputs is not established.129 Operational
research and sharing of on-the-ground experiences is
thought to be a useful learning resource, but with the
exception of a few examples,42 130 little published mater-
ial on operations is thought to exist.131 This is argued to
make it hard to learn from previous efforts and experi-
ence60 and determine why and how successes were
achieved.28
The paucity of monitoring and evaluation data is a
recognised problem,5 58 60 with authors attributing it to
long time-lags to achieve objectives,11 outcomes such as
organisational culture being difﬁcult to measure,11 lack
of commonly agreed and conceptually robust indica-
tors,59 60 102 and most evaluation data not being pub-
lished.129 To remedy this situation, guidance on
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Table 2 Summary of capacity development strategies designed to address specific barriers to health research
Barrier to research Strategies designed to address barriers to research Popularity (% of sources)
Fragmented research systems Undertake a situational analysis and build on existing
assets28 29 57 92
Collaboratively develop research agendas with LMIC
stakeholders55 70 75
Create a research coordinating body or scientific
councils29 64 93
Recently gaining popularity (12)
Insufficient research funding Establish a research finance system using innovative
revenue generation52 94 95
Provide long-term funding and flexible grants8 63 96
Advocate for funding through shared causes and engaging
with the media68 97
Growing popularity (21)
Limited use of research
evidence
Build capacities of policymakers to demand and scrutinise
research25 84 98
Develop evidence repositories and use
Research-to-Action-Groups as knowledge brokers to
package findings appropriately39 99
Create knowledge translation platforms to support
evidence dissemination and dialogue between research
producers and users30 39 64 100
Consistent popularity (11)
Limited governance and
regulatory capacity
Work research into a legislative framework64 101 102
Clarify guidelines, map review capacity and streamline
procedures74 103
Strengthen regulatory and ethical review capacity42 64
Growing popularity (21)
Insufficient networking Develop and share a database of researchers and their
expertise31
Use or develop professional networks, especially
web-based communities42 71
Organise conferences and working groups on locally
important topics2 104
Very popular (26)
Inefficient admin and research
management
Train management and research support staff29 105
Set up a research support office to help with grant
management, reporting and contracts, and develop
information and finance systems20 28 72
Develop transparent and accountable policies and
procedures69 106
Unpopular but increasing (8)
Inadequate material capacity Upgrade libraries and journal availability and invest in
laboratories28 89 91
Improve information technology, particularly internet6 78
Ensure stable power and water supplies89
Widely recognised (20)
Insufficient human capacity
with research knowledge and
skills
Develop LMIC university research training capacity using
‘train the trainer’ programmes, LMIC-HIC ‘sandwich’
courses or visiting research fellowships20 70 92 96 107–109
Make research principles and skills key components of
undergraduate and continuing professional medical
education37 70 110
Develop a variety of research roles: nurses, data
managers, statisticians, laboratory personnel, managers,
data collectors9 63 70 107 111–113
Increase distance learning via e-technologies or e-learning
resources26 41 70 114 115
Training in major skills gaps: data collection, data
management, data analysis and statistics, GCP, laboratory
skills, computer literacy and ethics46 51 54 107 116
Training in core capabilities: protocol development, writing
for grant applications and publication, grant management
and budgeting and policy dialogue29 45 55 63 117
Extremely popular (41).
Training in core capabilities
less popular (15)
Continued
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planning and implementing monitoring and evaluation
for health research has been developed,29 and one
research group provides online resources to help record
and share operational guidance.41
It was also clear from the literature that signiﬁcant
capacity gaps remain in many LMICs. Following the
example of clinical trials, authors point out that early
phase studies are still lacking132 and there are too few
quality research sites to meet demand.103 Despite
increases in some capacities, translation of ﬁndings into
policy is considered an enduringly difﬁcult
outcome60 133 and LMIC leadership and authorship in
studies is still thought to be too low.43 Reportedly insufﬁ-
cient political buy-in for strengthening investment in
health research has also raised concerns over the sustain-
ability of capacity development achievements.7 8 Some
authors argue that longer term projects and planning
for sustainability of research staff and services are
needed,103 but little literature explores this.63
DISCUSSION
An evolution in HRCD thinking
This literature synthesis has objectively presented the
main HRCD modalities and strategies and shows that
some development actors continue to operate research
models that are contrary to widely accepted views of best
practice, for example, expatriate led parallel research
units. Nevertheless, the literature reveals that there has
been steady progress in health research capacity in
LMICs. Development actors have continuously reas-
sessed their approaches and have become much more
reﬂexive of their actions. National stakeholders have
taken on a stronger voice and greater ownership and are
generally in a more self-sufﬁcient position.
Overall, development actors now agree that there is
no panacea or one-size-ﬁts-all model to HRCD. Instead a
plurality of solutions exists, the choice of which should
be determined by the speciﬁc capacities constraints and
research goals of LMIC institutions. However, despite
progress, major barriers to health research persist, there
is little evidence to support decision-making and the sus-
tainability of HRCD achievements is questionable.
HRCD, reality or just rhetoric?
The evolution in HRCD thinking appears promising,
but the literature demonstrates that good HRCD prac-
tices are not always enacted. While the requirement for
short-term projects is recognised,5 the vertical model has
been the dominant model for almost 20 years.58 This
would indicate that vertical approaches have been used
in situations that would be better served by longer term
Table 2 Continued
Barrier to research Strategies designed to address barriers to research Popularity (% of sources)
Insufficient practical research
experience
Supplement didactic training with research ‘learning by
doing’ opportunities40 47 55
Involve more LMIC institutional staff in research projects54
Exchange visits to advanced research sites to update
skills118
Pilot or small grants for early stage researchers to gain
experience53 119
Fairly accepted (11)
Too few research leaders Develop leadership, project and human resource
management skills8 72
Opportunities for junior staff to take responsibility within a
supportive environment20
In collaborative projects, local staff must be involved in the
entire research process120
Gaining popularity (13)
Too few mentors and role
models
Support mentors with long-term funded positions and
recognition73 78
Where mentoring is not available locally, institutional
partnerships/exchanges or peer mentorship can be
used9 11 55
Popular (15)
Lack of research culture Promote academic departmental leaders based on
research experience110
Set up a departmental committee to promote research121
Journal clubs and seminars to develop interest in research
and critical thinking70 118
Not popular (6)
Low motivation to conduct
research
Protected research time and longer term contracts54 76
Re-entry grants or guaranteed jobs to encourage ‘brain
drain’ diaspora to return home107 108
Higher salaries or funded research time to off-set
private-practice incentives76 122
Popular (18)
HIC, high income countries; LMIC, low and middle income countries.
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systems strengthening strategies.5 However, there are far
fewer programmes dedicated to implementing systems
approaches to capacity development. Other examples
include focusing on a few high proﬁle diseases,
donor-led research agendas, compulsory requirements
for collaboration with HICs, setting up parallel structures
and fragmentary competitive research. To make the
HRCD rhetoric a reality, there is a need to understand
why research models that do not enhance or potentially
inhibit locally led research remain the modus operandi,
even though there is clear agreement that they are bad
practice.
The literature ﬁndings clearly and frequently show
that the persistence of ﬂawed development strategies is
driven by approaching capacity development within the
context of a dedicated research model. This creates a
trade-off between doing good research and doing good
capacity development. Projects prioritising good
research place research outputs as the primary goal and
assume capacity will be developed through limited
LMIC involvement in research activities. This means
that speciﬁc development strategies designed to
improve capacity are not used. This ‘implicit’ capacity
development is known to be largely ineffective,63 72 yet
is it regularly used. As a result, local research systems
may fail to develop or deteriorate,22 and development
efforts are likely to become multiplicative and fragmen-
ted,60 92 despite overlapping interests and generic
requirements.71
The other main alternative is ‘explicit’ capacity devel-
opment. This refers to research projects that place more
priority on capacity development and use speciﬁc strat-
egies designed to address capacity gaps. There is wide
recognition that this is a superior approach and is more
likely to improve capacity sustainably.11 63 However,
because the research component is usually more valued
by the research community, capacity development
receives less attention and often focusses on developing
project-speciﬁc capacities, not addressing systemic deﬁ-
ciencies. Accordingly, the capacity development compo-
nent often becomes ‘bolted-on’ and ad hoc;11 28 thus
making it ‘implicit’ in disguise.
Instead, the review ﬁndings suggest that conducting
research to improve health in LMICs and developing
health research capacity in LMICs must be considered
two, sometimes diverging objectives. Recognising this
leads to a third way; ‘dedicated’ capacity development.
This implies that developing local capacity is as equally
valued as the research outputs and should be considered
as carefully as the research designs. Owing to the addi-
tional resources this requires, previous efforts have been
limited to individual capacity development or centres of
excellence.91 However, some capacity development
actors are now attempting to do this at a more systemic
level. Examples include: The Special Programme for
Research and Training in Tropical Disease’s (TDR)
implementation research programmes,3 ESSENCE on
Health Research134 and The Global Health Network.135
Implications for policy and practice
This systematic literature review provides an important
synthesis of HRCD that should prove useful for policy-
makers and practitioners alike. It identiﬁes the strengths,
limitations and controversies of the main development
approaches and summarises strategies that can be used
to overcome speciﬁc research system barriers.
Dedicated capacity development appears to offer the
best approach for achieving the WHO’s vision of all
nations becoming producers and users of research.1
However, a key barrier to designing development strat-
egies based on this thinking is the lack of empirical evi-
dence. Without operational and implementation
research and quality evaluation data, it is not possible to
know the relative effectiveness of different development
strategies and difﬁcult to predict if they will be appropri-
ate for a given context. The current experience of
sharing data is a good start, but more systematic empir-
ical research is required. This should be performed with
the same rigorous attention to methodological design,
analysis and reporting standards as any other research
endeavour.
Study strengths and limitations
Previous reviews of capacity development have lacked suf-
ﬁcient reﬂexivity and questioning of assumptions implicit
in many strategies.40 This systematic review produced a
nuanced and enquiring critique of HRCD approaches in
LMICs and has identiﬁed dedicated capacity develop-
ment as a promising strategy for future HRCD efforts. It
also integrated diverse qualitative literature that largely
lacked formal reporting procedures or empirical base,
allowing the inclusion of voices that are traditionally
excluded in other styles of systematic analyses.
Some academic articles may have been missed
because PubMed was the only formal database used and
non-English language articles were excluded. However,
the meta-narrative method aims to develop overarching
narratives through saturation of themes, rather than
include every eligible article, so using additional data-
bases would add little to the study. More problematic
was the limited availability and inclusion of programme
evaluations and evidence supporting operational learn-
ing. While expert opinion and the popularity of develop-
ment strategies were presented, it was apparent that this
is not a reliable indicator of good development practice.
Searching Google and Google Scholar, hand searching
literature collections and snowballing references did
identify the most seminal papers, but some useful organ-
isational documents will have been missed due to poor
grey literature indexing. Furthermore, most articles had
a general focus or related only to sub-Saharan Africa,
meaning that context-speciﬁc and research-speciﬁc dif-
ferences could not be examined in detail. The focus of
the literature on sub-Saharan Africa is likely due to the
high publishing rates of African authors and many
papers’ disease speciﬁc-focus on high burden diseases of
sub-Saharan Africa (HIV and malaria). However, it may
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also be possible that the English-language search restric-
tion excluded papers from authors publishing about
their region in non-English languages. Regardless, the
HRCD evidence gap in other developing regions is
notable.
It is also important to note that the literature search
was carried out on 20 June 2013, so only articles pub-
lished prior to this date were included in the analysis. A
literature scan was carried out on 14 December 2014
which found that the ﬁndings were still valid up to this
date. It is possible that due to the delay in publication of
this article further papers may have been published that
could contribute to the ﬁndings of this study. While this
means that this systematic review may not contain the
most up-to-date literature, it is the opinion of the
authors’ and peer reviewers’ that the study ﬁndings con-
tinue to be valid and of important relevance to the
global capacity development community. These asser-
tions are supported by the fact that major HRCD agen-
cies such as WHO-TDR and multiagency collaborations
such as ESSENCE on Health Research continue to view
the issues raised in this paper as problematic. Indeed
the 2016 revised version of ESSENCE’s Framework for
Research Capacity Strengthening136 reiterates the
importance of the guiding principles it set out in 2011,
while a contemporary WHO-TDR report on Key
Enabling Factors in Effective and Sustainable Research
Networks137 would suggest that these principles have not
yet been achieved.
The limited number of authors working on this review
reduced the breadth of perspectives involved during
analysis which could have biased interpretation towards
the authors’ particular knowledge paradigms and world
views. However, this was mitigated to some extent by
drawing on perspectives and experiences from concur-
rent research collaborators and participants, and
seeking feedback from relevant experts at meetings and
conferences. While some context-speciﬁc differences in
experiences were inevitably raised, all individuals who
were consulted considered the ﬁndings of this study to
be relevant and consistent with their broad view of
HRCD in LMICs. Although it may have been desirable
to have a second coder, this would not have necessarily
improved the validity of ﬁndings through intercoder reli-
ability comparisons because regardless of the number of
coders, the emerging coding scheme and ﬁndings
would always be subjective. Ensuring quality of interpret-
ation relies, rather, on being transparent in offering
explanations of meanings rather than presenting deﬁni-
tive causations, and explicitly acknowledging the subject-
ive nature of the analysis and the bias this creates. These
principles were adhered to in the research process and
the publication.
CONCLUSIONS
Despite gains in health research capacity and progress in
development thinking, further work is needed to
develop sustainable health research systems in LMICs.
One promising option is dedicated capacity develop-
ment in which capacity outcomes are as equally valued
as research outputs. However, more empirical research is
needed to identify the most effective strategies. If these
issues are successfully addressed, health research in all
nations could become a reality, rather than just rhetoric.
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